Google+ Facebook Twitter Twitter

Tech news: February 2022

This month's top tech news stories


CRP test CE mark

LumiraDx, a next-generation point-of-care diagnostics company, has announced its C-reactive protein (CRP) test has achieved CE marking. The LumiraDx CRP Test is a small, portable, fully automated, microfluidic immunoassay test used for the quantitative determination of CRP with results within four minutes.

The measurement of CRP provides important information for the detection and evaluation of infection, and inflammation.

Life Science Group

Cell shipment

A new product developed by Life Science Group and Coventry University has the potential to transform the delivery of cell and gene therapy and make cutting-edge, personalised treatments more accessible, it is claimed. CellShip is a cell shipment and storage medium. It is a sterile, xeno-free alternative to cryopreservation for the transport and short-term storage of cells and contains a non-toxic additive to maintain membrane integrity.



Sustainability report

Increasing the use of recycled materials in the manufacture of laboratory glasswashers and washer disinfectors is one of Miele’s goals to become more sustainable. The brand, which makes commercial dishwashers, washing machines and washer disinfectors, suitable for use in a laboratory and medical setting, has published a detailed sustainability report.

Miele plans to reduce CO2 by 50% by 2030 and is working to make its equipment easier to repair to increase each appliance’s life cycle.


Image credit | Shutterstock

Related Articles

British Journal of Biomedical Science: second quarter 2022

Deputy Editor Dr Mark Hajjawi gives a round-up of the papers published over recent months.

Tech news: June 2022

This month's top tech news stories

AI potential for breast cancer screening

A major new study shows that artificial intelligence (AI) is a promising tool for breast cancer detection in screening mammography programmes.

Revolutionary thinking

Another step has been taken in the battle against antimicrobial resistance with the development of a synthetic antibiotic.